CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 394 enrolled
Drug / intervention
2-chloroprocaine hydrochloride, 1%drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02067806
NCT02067806N/ACompleted
CompareCT.gov

Observational Prospective Study on 2-chloroprocaine Hydrochloride 1% Safety in Intrathecal Anesthesia

Sintetica SA·observational·Posted Feb 20, 2014·Updated Jun 29, 2021

In Brief

An observational study evaluating 2-chloroprocaine hydrochloride, 1% for Neurological Complication, in Particular TNS or CES. Completed, enrolled 394 participants across 1 site.

Detailed Summary

The present study aims to evaluate the relationship between spinal block with 1% solution of 2-chloroprocaine hydrochloride and the onset of all possible neurological adverse events, with particular attention to Transient Neurological Symptoms (TNS) and Cauda Equina Syndrome (CES).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNeurological Complication, in Particular TNS or CES
CountriesBelgium
CollaboratorsSintesi Research Srl

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedFeb 20, 2014
Enrollment StartNov 1, 2013
Primary CompletionOct 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 12.4 years ago

Interventions

2-chloroprocaine hydrochloride, 1%drug

Study included male and female adult patients undergoing spinal anesthesia with chloroprocaine, when the planned surgical procedure was not expected to exceeded 40 minutes.